IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC
`
`Petitioner,
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`
`Case No. IPR2016—0O204
`
`Patent No. RE 38,551
`
`PATENT OWNER RESEARCH CORPORATION TECHNOLOGIES,
`INC.’S MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC
`
`Petitioner,
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`
`Case No. IPR2016—0O204
`
`Patent No. RE 38,551
`
`PATENT OWNER RESEARCH CORPORATION TECHNOLOGIES,
`INC.’S MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016-00204
`
`Pursuant
`
`to 37 C.F.R.
`
`§ 42.8, Patent Owner Research Corporation
`
`Technologies, Inc. submits the following Mandatory Notices. In accordance with
`
`37 C.F.R. 42.8(a)(2), these Mandatory Notices are being timely filed within 21
`
`days of service of the petition.
`
`A.
`
`Real Party-In-Interest Under 37 C.F.R. § 42.8(b) (1)
`
`The real parties-in—interest are Research Corporation Technologies, Inc.;
`
`Harris FRC Corporation; UCB, Inc.; UCB Biopharma SPRL; and UCB Pharma
`
`GmbH.
`
`B.
`
`Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`The Patent Trial and Appeal Board denied an earlier filed Petition for Inter
`
`Partes Review of RE38,551, IPR2014-01126. Patent Owner further identifies the
`
`following related judicial proceedings involving RE38,551:
`
`Case Caption
`UCB, Inc. et al. v. Teva Pharmaceuticals USA Inc.
`et al., 1:13—cV—01148~LPS (D. Del.)
`UCB, Inc. et al. 12. Accord Healthcare Inc. et al. ,
`1:13—cv-01206-LPS (D. Del.)
`UCB, Inc. et al. v. Alembic Pharmaceuticals Ltd.,
`1:13—cv—01207—LPS (D. Del.)
`UCB, Inc. et al. v. Amneal Pharmaceuticals, LLC
`et al., 1:13~cv—01208—LPS (D. Del)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:13—cV—
`01209—LPS (D. Del.)
`UCB, Inc. et al. v. Aurobindo Pharma Ltd. et al.,
`1:13—cv-01210-LPS (D. Del.)
`UCB, Inc. et al. v. Breckenridge Pharmaceutical
`Inc. et al., 1:13-cv~01211-LPS (D. Del.)
`
`Disp_0sition
`closed
`
`pending
`
`Al
`
`pending, consolidated with
`1:13-cv—01206-LPS (D. Del.)
`pending, consolidated with
`1:13—cv—0l206—LPS (D. Del.)
`pending, consolidated with
`1:13—cv~O1206—LPS (D. Del.)
`pending, consolidated with
`1:13—cv-O1206—LPS (D. Del.)
`pending, consolidated with
`1:13-cv—01206—LPS (D. Del) J
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR20l6—0O204
`
`pending, consolidated with
`1:13—cv—0l206—LP§_(D. Del.)
`closed
`
`closed
`
`closed
`
`J Disposition
`Case Caption
`UCB, Inc. et al. v. Glenmark Generics Inc. USA et Closed
`al., 1:13-cV—0l2l2-LPS (D. Del)
`UCB, Inc. et al. V. Hetero USA Inc. et al., 1:13—cV— Closed
`O12l3—LPS
`Del.)
`UCB, Inc. et al. v. Mylan Pharmaceuticals Inc. et
`al., 1:l3—Cv-—Ol214—LPS (D. Del.)
`UCB, Inc. et al. v. Ranbaxy Laboratories Ltd. et
`al., 1:13—cV—Ol2l5—LPS (D. Del.)
`UCB, Inc. et al. v. Sandoz Inc., 1:l3—cV—0l216—
`LPS (D. Del.)
`UCB, Inc. et al. v ScieGen Pharmaceuticals Inc. et
`al., 1:l3—CV—O12l7—LPS (D. Del.)
`UCB, Inc. et al. v Sun Pharma Global FZE et al.,
`1:13-CV-01218-LPS (D. Del.)
`UCB, Inc. et al. 12. Watson Laboratories Inc. —
`Florida et al., 1:l3—cv—O1219—LPS (D. Del)
`UCB, Inc. et al. v. Zydus Pharmaceuticals (USA)
`Inc. et al., l:l3—cV-0l22O—LPS (D. Del.)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:14—cV—
`00834-LPS (D. Del.)
`UCB, Inc. et al. v. Sun Pharma Global FZE et al.,
`1:l3—cv~055l4
`Ill.)
`UCB, Inc. et al., v. Zydus Pharmaceuticals (USA),
`Inc. et al., 3:l3—CV—O402l (D.N.J.)
`
`pending, consolidated with
`1:l3—CV—01206—LPS (D. Del.)
`pending, consolidated with
`[ 1:13-cv—01206-LPS (D. Del.)
`pending, Consolidated with
`1:13—cv—01206—LPS (D. Del.)
`pending, consolidated with
`1:13-cv—01206-LPS (D. Del.)
`closed
`
`closed
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016-00204
`
`C.
`
`Lead and Back-Up Counsel Under 37 C.F.R. § 42.8(b)(3)
`
`i
`
`Back-Up Counsel
`Jennifer L. Robbins (Reg. No. 61,163)
`jrobbins@cov.com
`Postal and Hand—Delivery Address:
`Covington & Burling LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Telephone: (212) 841-1180
`Facsimile: (212) 841-1010
`
`I
`
`1
`
`Lead Counsel
`
`Andrea G. Reister (Reg. No. 36,253)
`areister@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Telephone: (202) 662-5141
`Facsimile: (202) 778-5141
`
`Additional Back-Up Counsel
`Enrique D. Longton (Reg. No. 47,304)
`rlongton@cov.com
`Postal and Hand~Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Telephone: (202) 662-5108
`Facsimile: (202)778-5108
`
`D.
`
`Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`Service information for lead and back-up counsel
`
`is provided in the
`
`designation of lead and back-up counsel, above. Service of any documents via
`
`hand—delivery may be made at the postal mailing address of the respective lead and
`
`back-up counsel designated above.
`
`Patent Owner Reseach Corporation
`
`Technologies, Inc. consents to electronic service by email at the above listed email
`
`addresses of lead and back-up counsel.
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016—00204
`
`E.
`
`Power of Attorney
`
`A Power of Attorney to transact all business in the United States Patent &
`
`Trademark Office (“USPTO”) in connection with the above-referenced Inter
`
`Partes Review from Patent Owner Research Corporation Technologies, Inc. to the
`
`above-designated counsel at Covington & Burling LLP is being filed concurrently
`
`with these Mandatory Notices. The Power of Attorney is accompanied by a
`
`Statement Under 37 C.F.R. § 3.73(b), executed by the Patent Owner.
`
`
`Date: December 9 2015
`
`Respectfully submitted,
`
`/‘By/‘ii/’:[7”V“"</’é”é:j”X
`
`
`Andrea G. Reister
`
`‘:
`
`Registration No. 36,253
`Jennifer L. Robbins
`
`Registration No. 61,163
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 9th day of December
`
`2015,
`
`the foregoing Patent Owner Research Corporation Technologies, Inc.’s
`
`Mandatory Notices Under 37 C.F.R. § 42.8 was served by FedEx®, a means at least
`
`as fast and reliable as Priority Mail Express®, on the following counsel of record
`
`for petitioner.
`
`Matthew J. Dowd (matthewdowd@andrewskurth.corn)
`Justin W. Crotty, Ph.D. (justincrotty@andrewskurth.com)
`ANDREWS KURTH LLP
`
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`
`Date: December 9, 2015
`
`/’“\
`
`
`
`///
`M {I
`E
`F»
`3;»
`~
`/0
`
`
`Andrea G. Reistér, Esq.
`Registration No; 36,253
`
`‘
`*”" ft.
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
